Intravenous iron therapy: well-tolerated, yet not harmless (Q36310902)

13 August 2017

1 reference

title

Intravenous iron therapy: well-tolerated, yet not harmless (English)

1 reference

13 August 2017

Sengölge G

1

1 reference

13 August 2017

Hörl WH

series ordinal

2

1 reference

13 August 2017

Sunder-Plassmann G

series ordinal

3

1 reference

13 August 2017

publication date

1 December 2005

1 reference

European Journal of Clinical Investigation

13 August 2017

published in

1 reference

13 August 2017

volume

35 Suppl 3

1 reference

13 August 2017

page(s)

46-51

1 reference

The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Role of free radicals and catalytic metal ions in human disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron sucrose: the oldest iron therapy becomes new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

The role of iron in infections with intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Infections in E-beta thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron chelation improves endothelial function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

A low serum iron level is a predictor of poor outcome in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Administration of parenteral iron and mortality among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Parenteral iron nephrotoxicity: potential mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Impairment of transendothelial leukocyte migration by iron complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron Chelators Inhibit VCAM-1 Expression in Human Dermal Microvascular Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Restored vulnerability of cultured endothelial cells to high glucose by iron replenishment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Haem, haem oxygenase and ferritin in vascular endothelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Characterization of iron uptake from transferrin by murine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Enhancement by iron of interleukin 1 induced granulocyte macrophage colony stimulating factor (GM-CSF) production by human synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01530.X

10.1111/J.1365-2362.2005.01530.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference